Ketamine (0.5 mg/kg)
Ketamine (0.5 mg/kg) is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Ketamine Biomarker Validation
Sedative and Analgesic Effects of Dexmedetomidine Versus Ketamine in Patients Undergoing Varicocelectomy Under Spinal Anaesthesia: A Prospective Randomized Comparative Trial
Effect of Different Anesthetic Drugs on Electrocorticography (ECOG).
Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
Clinical Trials (5)
Ketamine Biomarker Validation
Sedative and Analgesic Effects of Dexmedetomidine Versus Ketamine in Patients Undergoing Varicocelectomy Under Spinal Anaesthesia: A Prospective Randomized Comparative Trial
Effect of Different Anesthetic Drugs on Electrocorticography (ECOG).
Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5